Related Experiment Videos

Nonoprerative management of obstructive jaundice caused by a benign hepatic cyst

Masao Ogawa1, Shoji Kubo, Takahiro Uenishi

  • 1Department of Gastroenterological and Hepato-Biliary-Pancreatic Surgery, Osaka City University, Graduate School of Medicine, Japan. m0035881@msic.med.osaka-cu.ac.jp

Osaka City Medical Journal
|April 12, 2005
PubMed

Insights

Minocycline hydrochloride effectively treats large benign hepatic cysts causing jaundice by shrinking them. This method offers a safe alternative to ethanol for managing obstructive jaundice from liver cysts.

Area of Science:

  • Hepatology
  • Gastroenterology
  • Interventional Radiology

Background:

  • Benign hepatic cysts can cause significant complications, including obstructive jaundice due to biliary tree compression.
  • Percutaneous management of hepatic cysts is an established treatment modality.

Observation:

  • A 64-year-old male presented with obstructive jaundice secondary to a large (9.0 cm) benign hepatic cyst near the hepatic hilum.
  • The cyst was treated via percutaneous aspiration followed by the instillation of minocycline hydrochloride as a sclerosant.

Findings:

  • The hepatic cyst gradually reduced in size post-treatment.
  • Obstructive jaundice resolved completely without complications or reported side-effects.
  • Minocycline hydrochloride demonstrated efficacy as a sclerosant in this case.

Implications:

  • Minocycline hydrochloride instillation presents a viable and safe alternative to ethanol for sclerotherapy of benign hepatic cysts.
  • This approach is effective even in cases where cysts cause obstructive jaundice, offering a less invasive option.
  • Further research into minocycline hydrochloride as a sclerosant for hepatic cysts is warranted.

Related Concept Videos

Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment: